Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.43 |
| ▸ | CTSL | P07711 | 1/20 | 0.42 |
| ▸ | UBE2M | P61081 | 3/20 | 0.42 |
| ▸ | DCUN1D1 | Q96GG9 | 3/20 | 0.42 |
| ▸ | CCR5 | P51681 | 3/20 | 0.40 |
| ▸ | CCR1 | P32246 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 1/20 | 0.38 |
| ▸ | CTSK | P43235 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2797116 | 0.85 | GPR119 (0.49) | KMT2ATHRBUBE2MDCUN1D1CCR5 | |
| SCHEMBL2791118 | 0.84 | THRB (0.45) | THRBUBE2MDCUN1D1CCR5CCR1 | |
| Hydrochloric Acid SCHEMBL2791115 | 0.84 | THRB (0.44) | THRBUBE2MDCUN1D1CCR5CCR1 | |
| Hydrochloric Acid SCHEMBL2791119 | 0.84 | THRB (0.44) | THRBUBE2MDCUN1D1CCR5CCR1 | |
| SCHEMBL2797087 | 0.83 | THRB (0.39) | THRBCTSLUBE2MDCUN1D1CCR1 | |
| SCHEMBL2907313 | 0.80 | THRB (0.49) | THRBUBE2MDCUN1D1CCR5 | |
| SCHEMBL2797093 | 0.80 | THRB (0.38) | THRBCTSLUBE2MDCUN1D1CCR5 | |
| SCHEMBL2797092 | 0.80 | THRB (0.38) | THRBCTSLUBE2MDCUN1D1CCR5 | |
| SCHEMBL9546510 | 0.80 | CCR1 (0.54) | KMT2ACTSLCCR5CCR1MAPK1 | |
| SCHEMBL9546604 | 0.76 | CCR1 (0.56) | KMT2ACTSLCCR5CCR1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100168421-A1 | A NEW PEPTIDE DEFORMYLASE INHIBITOR COMPOUND AND MANUFACTURING PROCESS THEREOF | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2010-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168421-A1 | A NEW PEPTIDE DEFORMYLASE INHIBITOR COMPOUND AND MANUFACTURING PROCESS THEREOF | PDF, PEPD, DPEP1 | KMT2A 2750/4885THRB 3339/4885CTSL 220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.